These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2949582)

  • 21. Left ventricular hypertrophy and antihypertensive therapy.
    Graettinger WF; Weber MA
    Am Fam Physician; 1992 Aug; 46(2):483-91. PubMed ID: 1386180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Heart effect of arterial hypertension. Heart hypertrophy as a risk factor. Study technics (electrocardiogram, echocardiography, exercise test and Holter].
    Aguilera Saldaña MA; García Moreno LM; Rodríguez Padial L; Navarro Lima A; Sánchez Domínguez J
    Rev Esp Cardiol; 1990; 43 Suppl 1():54-64. PubMed ID: 2139976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor.
    Messerli FH; Ketelhut R
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S7-13. PubMed ID: 7507540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamics and other determinants in development of left ventricular hypertrophy.
    Frohlich ED
    Fed Proc; 1983 Jul; 42(10):2709-15. PubMed ID: 6222919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population implications of electrocardiographic left ventricular hypertrophy.
    Kannel WB; Dannenberg AL; Levy D
    Am J Cardiol; 1987 Dec; 60(17):85I-93I. PubMed ID: 2961250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of cardiac risk in hypertensive patients with left heart hypertrophy].
    Schulte KL; Meyer-Sabellek W; Liederwald K; Eisenhut C; Distler A; Gotzen R
    Z Kardiol; 1991; 80 Suppl 1():37-40. PubMed ID: 1827230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salt sensitivity and left ventricular hypertrophy.
    Coca A; De la Sierra A
    Adv Exp Med Biol; 1997; 432():91-101. PubMed ID: 9433515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrosis and ischemia: the real risks in hypertensive heart disease.
    Frohlich ED
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):194S-199S. PubMed ID: 11411756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular hypertrophy: dissociation of structural and functional effects by therapy.
    Frohlich ED
    Adv Exp Med Biol; 1991; 308():175-90. PubMed ID: 1839347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Considerations in treating hypertension: focus on risk factors.
    Messerli FH
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():3-6. PubMed ID: 2151045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac involvement in hypertension.
    DiPette DJ; Frohlich ED
    Am J Cardiol; 1988 Jun; 61(16):67H-72H. PubMed ID: 2968038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of rhythm disorders in cardiac hypertrophy.
    McLenachan JM; Dargie HJ
    Am J Cardiol; 1990 Apr; 65(14):42G-44G. PubMed ID: 2138856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic hypertension, left ventricular hypertrophy and coronary artery disease.
    Tubau JF; Szlachcic J; London MJ; Hollenberg M; Mangano D; Massie BM
    Am J Cardiol; 1987 Dec; 60(17):23I-28I. PubMed ID: 2961247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiological considerations in left ventricular hypertrophy.
    Frohlich ED
    J Clin Hypertens; 1987 Mar; 3(1):54-65. PubMed ID: 2952767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventricular arrhythmias in hypertension: in which patients do they occur?
    Mayet J; Shahi M; Poulter NR; Sever PS; Thom SA; Foale RA
    J Hypertens; 1995 Feb; 13(2):269-76. PubMed ID: 7615959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial remodeling in hypertension.
    Nadruz W
    J Hum Hypertens; 2015 Jan; 29(1):1-6. PubMed ID: 24804791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular hypertrophy: further evidence of risk.
    Frohlich ED
    J Am Coll Cardiol; 1991 Nov; 18(5):1295-6. PubMed ID: 1833431
    [No Abstract]   [Full Text] [Related]  

  • 38. Regression of left ventricular mass in systemic hypertension.
    Georgiou D; Brundage BH
    Clin Cardiol; 1992 Jan; 15(1):5-16. PubMed ID: 1531790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of increased left ventricular mass by antihypertensives.
    Lavie CJ; Ventura HO; Messerli FH
    Drugs; 1991 Dec; 42(6):945-61. PubMed ID: 1724641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.